Healthcare finance experts warn the industry’s sluggish evolution toward paying to keep people healthy may slip next year as providers fight to keep their heads above water. Medical services are still overwhelmingly paid for on a fee-for-service basis, a setup that’s widely blamed for out-of-control costs. The need for value-based reimbursement has long been recognized…
Read more
To give the experts who bring you insights daily based on their experience as investors, entrepreneurs & executives a break during this holiday season (for some people), we are reposting the most popular posts from last 5 years. Todays post was the most popular in 2021 but was actually posted late in in 2020 Should…
Read more
In terms of price, bitcoin climbed from around $29,000 at the start of the year to a fresh all-time high of nearly $69,000 in November, and in the process, it reached a market cap of more than $1 trillion for the first time. Bitcoin began the year being the institutional favorite, with multinationals and hedge…
Read more
Near the edge of Yellowstone National Park in Wyoming, a group of cryptocurrency enthusiasts have launched a new experiment in city building — just don’t ask who is going to be mayor. The collective, CityDAO, has no official leader. Its members organise themselves using the chat app Discord. Every major decision must go up for…
Read more
Over the past decade, Instagram has created a new kind of entrepreneur. Anyone can start a page and post pictures for free, giving founders access to over 1bn potential customers. And during the pandemic the platform has been essential to helping some small businesses survive. “[Instagram] was my lifeline,” says Catherine Sharman, chief executive and…
Read more
In China, start-up companies in the field of drug discovery are emerging one after another, dovetailing with a push by the administration of President Xi Jinping to advance China’s pharmaceutical industry. Now a country long known for producing generics and active pharmaceutical ingredients — the raw materials for precursors — has also begun to discover…
Read more
Worried that a new COVID-19 wave could overwhelm understaffed U.S. hospitals, federal officials on Thursday loosened rules that call on healthcare workers to stay out of work for 10 days if they test positive. Those workers now will be allowed to come back to work after seven days if they test negative and don’t have…
Read more
Chania Batten has as much reason as anybody to feel pandemic fatigue. As a nurse staffing a drive-thru clinic at the only hospital in rural Roane County, West Virginia, she has spent months patiently answering questions, dispelling misinformation and reassuring the skeptical that COVID-19 shots are the key to beating back the coronavirus. Batten shudders…
Read more
Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. The challenge is getting tested, getting a prescription and starting the pills in a short window. U.S. regulators authorized Pfizer’s…
Read more
Moderna is fighting a shareholder proposal demanding the pharma group open up its Covid-19 vaccine technology to poorer countries and explain why its prices are so high given the amount of government assistance it has received. Legal & General Investment Management, the London-based asset manager, said Moderna’s shareholders deserve to know how US government funding…
Read more